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Introduction - The role of the epicardial adipose tissue (EAT) as a risk factor for coronary artery disease (CAD) remains unclear. There are no 
clinical studies of EAT in people with CAD and few EAT studies have assessed long term outcomes. We therefore sought to investigate the relationship 
between EAT and recurrence of cardiovascular events in patients with CAD.
Methods - The study population consisted of a cohort of 194 consecutive patients with CAD who entered a Phase II cardiac rehabilitation program 
and had a transthoracic echocardiogram performed within 6 months after the patient entered the rehabilitation program. The maximum EAT was 
measured on the free wall of the right ventricle, using the aortic annulus as reference, at the parasternal long-axis view at end-systole in 3 cardiac 
cycles. The average of 3 measurements was calculated and patients were classified as having EAT above or below the mean. The primary outcome 
was the incidence of major adverse cardiovascular events (MACE) and included acute coronary syndrome, coronary revascularization, stroke, 
ventricular arrhythmias or death.
Results - The mean age was 59.4±10.8 years and BMI was 28.7±4.6 kg/m2; 80% were males and 21% of the patients underwent coronary 
artery bypass graft (CABG). Mean follow-up time was 3.6±1.3 years and there were 57 MACE at follow-up. The group with values above the mean 
EAT were older (61.8±1.1 years vs 57.1±1.1 years, p=0.003). There were no significant differences in BMI, body fat percentage, lean weight and 
waist circumference between groups. There was no difference in MACE comparing the groups with EAT above the mean versus EAT below the mean 
(HR=1.23; 95%CI=0.73-2.1; p=0.43). The results persisted after adjusting for age, gender and BMI (HR for the EAT group above the mean=1.19; 
95%CI=0.68-2.06; p=0.53). EAT had a non-significant trend for MACE when stratified by tertiles (HR for the second tertile=1.15; 95%CI= 0.55-2.38; 
p=0.71; HR for the third tertile=1.75; 95%CI=0.88-3.5; p=0.11).
Conclusion - The results of this longitudinal study suggest that EAT, as measured with echocardiography, is not strongly associated with MACE in 
patients with CAD.
